Samil Pharmaceutical Co.,Ltd (000520.KS) KSC
8,650.00
+0(+0.00%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
8,650.00
+0(+0.00%)
Currency In KRW
| Market Cap | 205.88B |
| Enterprise Value | 363.49B |
| P/E Ratio | -5.31 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 0.87 |
| Price/Book Ratio | 1.38 |
| Enterprise/Revenue | 1.62 |
| Enterprise/EBITDA | -31.82 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.16 |
| Operating Margin | -0.11 |
| Return On Assets | -0.09 |
| Return On Equity | -0.23 |
| Revenue | 210.37B |
| Revenue/Share | 9,901.1 |
| Gross Profit | 67.44B |
| EBITDA | -10.72B |
| Net Income | -34.59B |
| Diluted EPS | -1,627.95 |
| Total Cash | 6.41B |
| Total Cash/Share | 301.83 |
| Total Debt | 164.02B |
| Total Debt/Equity | 1.23 |
| Current Ratio | 0.44 |
| Book Value Per Share | 6,272.04 |
| 52-Week Change | -30.3 |
| 52-Week High | 13,300 |
| 52-Week Low | 8,520 |
| Moving Average 50 Days | 9,761.2 |
| Moving Average 200 Days | 10,078.7 |
| Average Volume | 287,693 |
| Shares Outstanding | 21.23M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 11:10 |
| Last Split Date | March 24, 2023 |